called osteonecrosis of the jaw. Now let me say right now, immediately, that I think the risk of this condition in somebody on one of these drugs for osteoporosis is extremely low. What we've ...

Dr Migliorati further suggests that such a study could uncover important information about the pathobiology of ONJ and identify possible risks of its development. Clinicians must weigh the risks ...